Go back to News
NEWS
GA_P advises Uriach on the minority investment in ICG and the acquisition of French group Laboratories Ineldea
15 November, 2023
AGómez-Acebo & Pombo has advised Grupo J. Uriach, a Catalan company specialising in the Natural Consumer Healthcare sector, on the entry of the private equity fund ICG in its share capital and on the simultaneous acquisition of the French group Laboratories Ineldea.
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of Corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. Uriach Group. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of Competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Read full article
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
¡NEW! 
PUBLICATION
¡NEW!
Voluntary takeover bids and squeeze-outs
The Judgment of the Court of Justice of the European Union (Fifth Chamber) of 13 May 2026 (Korfin and Sempiola v Slovnaft, Case C-225/25) clarifies the concept of a takeover bid for the purposes of Article 2 of the 2004 Takeover Bids Directive, such that an offer made to the holders of securities of a company with a view to acquiring all or some of those securities does not fall within the concept of a takeover bid where it is made by an offeror who already controls the offeree company. Consequently, based on that court’s interpretation of the Directive’s provisions, there is no right of squeeze-out in such voluntary takeover bids.
¡NEW! 
PUBLICATION
2 days ago
An action for declaration of invalidity of an already-terminated franchise agreement is admissible
An action for declaration of invalidity of an agreement can almost always be brought, even if the agreement has been performed and terminated.
2 days ago
PUBLICATION
18 May, 2026
Automotive and Sustainable Mobility No. 30
Summary of legislative and jurisprudential developments relating to the automotive sector.
18 May, 2026
PUBLICATION
30 Apr, 2026
Pharma & Healthcare No. 48
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
30 Apr, 2026
PUBLICATION
21 Apr, 2026
The 28th Corporate Regime: the EU Inc.
The Proposal for a Regulation of the European Parliament and of the Council on the 28th Regime Corporate Legal Framework – ‘EU Inc.’, dated 18 March 2026, introduces a new form of European private limited company. Originally envisaged for start-ups and scale-ups, it has been decided to allow its adoption by all companies. There is no minimum share capital requirement; shares may have no nominal value and may carry multiple voting rights, among other features. The Commission is expected to approve model articles of association so that a company can be incorporated online in less than forty-eight hours and for less than one hundred euros.
21 Apr, 2026
PUBLICATION
17 Apr, 2026
Can a framework agreement lacking an exclusivity or minimum orders clause be discharged by breach?
All cases decided by the Supreme Court and their specific details are discussed. There is no single solution to the problem of terminating a framework supply of services agreement without an exclusivity clause or a minimum purchases obligation.
17 Apr, 2026
PUBLICATION
12 Mar, 2026
European reform of the sustainability reporting regime under Directive (EU) 2026/470: consequences of its non-transposition into domestic law
Directive (EU) 2026/470 (Omnibus I) has been published, limiting the obligation to prepare a sustainability report to public-interest entities with more than 1,000 employees and a net turnover of more than €450 million during the preceding financial year, as well as to parent companies of a large group that exceed these figures on a consolidated basis. The Directive amends the audit directive, the accounting directive, the corporate sustainability reporting directive (CSRD) and the corporate sustainability due diligence directive (CSDDD).
12 Mar, 2026
PUBLICATION
11 Mar, 2026
Uncertificated share pledge creation, enforceability and avoidance (Supreme Court Judgment no.183/2026 of 10 February)
In Judgment no. 183/2026, of 10 February, the Supreme Court analysed the requirements for the validity and enforceability of an uncertificated registered share pledge and examined the conditions for its avoidance in the context of insolvency proceedings.
11 Mar, 2026
PUBLICATION
26 Feb, 2026
Pharma & Healthcare No. 47
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
26 Feb, 2026